Multicenter Laboratory Validation of Susceptibility Testing of Mycobacterium tuberculosis against Classical Second-Line and Newer Antimicrobial Drugs by Using the Radiometric BACTEC 460 Technique and the Proportion Method with Solid Media
- 1 October 1999
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 37 (10) , 3179-3186
- https://doi.org/10.1128/jcm.37.10.3179-3186.1999
Abstract
In a large multicenter study involving six major study sites in the United States, Canada, and Europe, the susceptibilities of 272 Mycobacterium tuberculosis strains to classical second-line antituberculosis (anti-TB) drugs (capreomycin, cycloserine, ethionamide, and kanamycin) and newer compounds (amikacin, clofazimine, ofloxacin, and rifabutin) were determined by the radiometric BACTEC 460 procedure and the conventional proportion method on Middlebrook 7H10 agar. Previously established critical concentrations for classical second-line anti-TB drugs were compared with several concentrations in liquid medium to establish equivalence. MICs of newer compounds determined in liquid medium were either the same or up to four times lower than those determined in agar medium. After establishing critical concentrations (breakpoints) in the extended testing of clinical isolates, we obtained an excellent overall correlation between the two systems, with no errors with amikacin, kanamycin, and ofloxacin and very few major or very major errors with the other drugs; however, for cycloserine, no breakpoint concentration could be recommended due to repeatedly inconsistent results by both methods. Based on these data we conclude that the BACTEC 460 procedure is a simple and rapid method requiring 4 to 8 days on average to generate accurate antimicrobial susceptibility testing (AST) results for eight anti-TB drugs other than those considered primary ones. These data not only fill a major gap of knowledge regarding the critical test concentrations of secondary anti-TB drugs but also provide a baseline for future evaluations of M. tuberculosis AST with the more recently developed, nonradiometric broth-based culture systems.Keywords
This publication has 29 references indexed in Scilit:
- In Vitro Activities of Fourteen Antimicrobial Agents Against Drug Susceptible and Resistant Clinical Isolates of Mycobacterium tuberculosis and Comparative Intracellular Activities Against the Virulent H37Rv Strain in Human MacrophagesCurrent Microbiology, 1996
- Setting breakpoints for assessing the sensitivity of mycobacteria to rifabutin in vitroJournal of Antimicrobial Chemotherapy, 1994
- Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1993
- Stability of antimycobacterial drugs in susceptibility testingAntimicrobial Agents and Chemotherapy, 1992
- Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosisAntimicrobial Agents and Chemotherapy, 1989
- Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosisResearch in Microbiology, 1989
- Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against mycobacterium tuberculosis and mycobacterium avium complexTubercle, 1987
- Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1986
- In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasiiAntimicrobial Agents and Chemotherapy, 1984
- Amikacin in the treatment of pulmonary tuberculosisTubercle, 1983